Anlotinib as a post-third-line therapy for the treatment of advanced nonsmall cell lung cancer

Li, L; Liu, W; Wang, YC; Zhang, Q; Chi, CZ; Bai, QH; Xu, CH; Yang, RS

Xu, CH; Yang, RS (corresponding author), Nanjing Med Univ, Dept Resp Med, Affiliated Nanjing Brain Hosp, Nanjing 210029, Peoples R China.

JOURNAL OF CHEMOTHERAPY, ; ():

Abstract

There is no standard treatment strategy for the third-line and above treatment of advanced nonsmall cell lung cancer (NSCLC). This study aimed to inve......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索